USRE33994E
(en)
*
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
CA1239034A
(en)
*
|
1984-08-17 |
1988-07-12 |
Kelly L. Smith |
Delivery system
|
JPS62223112A
(ja)
*
|
1986-03-25 |
1987-10-01 |
Rooto Seiyaku Kk |
歯周病治療剤
|
JPH0759496B2
(ja)
*
|
1986-03-25 |
1995-06-28 |
ロ−ト製薬株式会社 |
歯周病治療剤
|
US5196202A
(en)
*
|
1986-09-01 |
1993-03-23 |
Teikoku Seiyaku Kabushiki Kaisha |
Sustained release dosage form
|
JPH0794384B2
(ja)
*
|
1986-09-01 |
1995-10-11 |
帝国製薬株式会社 |
徐放性口腔内用製剤
|
US5230901A
(en)
*
|
1988-03-23 |
1993-07-27 |
Knoll Ag |
Sustained release tablet of a mixture of alginates and polyacrylates
|
DE3809764A1
(de)
*
|
1988-03-23 |
1989-10-05 |
Knoll Ag |
Mischung aus alginaten und polyacrylaten und deren verwendung
|
US5047244A
(en)
*
|
1988-06-03 |
1991-09-10 |
Watson Laboratories, Inc. |
Mucoadhesive carrier for delivery of therapeutical agent
|
EP0452334A4
(en)
*
|
1989-10-31 |
1991-12-11 |
Watson Laboratoires, Inc. |
Mucoadhesive carrier for delivery of therapeutical agent
|
US5750134A
(en)
*
|
1989-11-03 |
1998-05-12 |
Riker Laboratories, Inc. |
Bioadhesive composition and patch
|
US5750136A
(en)
*
|
1989-11-03 |
1998-05-12 |
Riker Laboratories, Inc. |
Bioadhesive composition and patch
|
EP0451433B1
(de)
*
|
1990-04-12 |
1996-10-23 |
Janssen Pharmaceutica N.V. |
Zusammensetzung zur Anwendung eines Arzneimittels, bestehend aus einem Bioadhäsiven Trägerstoff mit verzögerter Freisetzung
|
US5113860A
(en)
*
|
1991-03-15 |
1992-05-19 |
Minnesota Mining And Manufacturing Company |
Non-invasive transmucosal drug level monitoring method
|
GB9200607D0
(en)
*
|
1992-01-13 |
1992-03-11 |
Ethical Pharma Ltd |
Pharmaceutical compositions containing nifedipine and process for the preparation thereof
|
US5292517A
(en)
*
|
1992-02-25 |
1994-03-08 |
Allergan, Inc. |
pH sensitive, reversible gelling, copolymeric erodible drug delivery system
|
EP0641192B1
(de)
*
|
1992-05-18 |
1997-07-23 |
Minnesota Mining And Manufacturing Company |
Einrichtung zur transmucosalen wirkstoffabgabe
|
GR1002418B
(el)
*
|
1992-07-29 |
1996-08-21 |
Johnson & Johnson Consumer Products Inc. |
Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης.
|
WO1994005262A1
(en)
*
|
1992-09-10 |
1994-03-17 |
F.H. Faulding & Co. Limited |
Sustained release matrix composition
|
US5330761A
(en)
*
|
1993-01-29 |
1994-07-19 |
Edward Mendell Co. Inc. |
Bioadhesive tablet for non-systemic use products
|
EP0664695A1
(de)
*
|
1993-08-06 |
1995-08-02 |
William J. Embro |
Verfahren und mittel zur behandlung von mukoepidermalen und epidermalen schmerzen, entzündungen und infektionen
|
FR2710265B1
(fr)
*
|
1993-09-22 |
1995-10-20 |
Adir |
Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
|
US5451411A
(en)
*
|
1993-10-15 |
1995-09-19 |
University Of Washington |
Methods and compositions for the oral delivery of therapeutic agents
|
US5578315A
(en)
*
|
1993-12-01 |
1996-11-26 |
Rutgers, The State University Of New Jersey |
Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
|
FR2718020B1
(fr)
*
|
1994-04-01 |
1996-05-31 |
Biotec Centre Sa |
Composition galénique mucoadhésive hétérofonctionnelle.
|
ATE390132T1
(de)
*
|
1994-09-16 |
2008-04-15 |
Hisamitsu Pharmaceutical Co |
Pflaster zur externen anwendung
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
US5773031A
(en)
*
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
US6458574B1
(en)
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
US6083725A
(en)
*
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
WO1998022097A2
(en)
*
|
1996-11-20 |
1998-05-28 |
Bio Advances, Llc |
Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
|
GB2328443B
(en)
|
1997-08-21 |
2001-09-05 |
Reckitt & Colmann Prod Ltd |
In situ formation of pharmaceutically acceptable polymeric material
|
US6624200B2
(en)
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6248358B1
(en)
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US20040018241A1
(en)
*
|
1997-09-26 |
2004-01-29 |
Noven Pharmaceuticals, Inc. |
Bioadhesive compositions and methods for topical administration of active agents
|
CA2304958C
(en)
*
|
1997-09-26 |
2008-12-30 |
Noven Pharmaceuticals, Inc. |
Bioadhesive compositions and methods for topical administration of active agents
|
US20050048102A1
(en)
*
|
1997-10-16 |
2005-03-03 |
Virotex Corporation |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
US6074674A
(en)
*
|
1997-10-31 |
2000-06-13 |
University Of Kentucky Research Foundation |
Formulations for sustained-release of topical anesthetics and methods of making and using same
|
US20020127254A1
(en)
*
|
1998-06-25 |
2002-09-12 |
Lavipharm Laboratories Inc. |
Devices for local and systemic delivery of active substance and methods of manufacturing thereof
|
AU2003200753B2
(en)
*
|
1998-08-25 |
2005-05-12 |
Columbia Laboratories (Bermuda) Limited |
Bioadhesive Progressive Hydration Tablets
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6210699B1
(en)
|
1999-04-01 |
2001-04-03 |
Watson Pharmaceuticals, Inc. |
Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
|
US20070048882A1
(en)
*
|
2000-03-17 |
2007-03-01 |
Applied Materials, Inc. |
Method to reduce plasma-induced charging damage
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
HUP0002628A2
(en)
*
|
2000-07-14 |
2002-06-29 |
Keri Pharma Kft |
Pharmaceutical combinations for treating diabetes
|
US6756051B1
(en)
*
|
2000-11-15 |
2004-06-29 |
Li-Lan H. Chen |
Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
|
EP2324821A1
(de)
*
|
2001-02-28 |
2011-05-25 |
Axiomedic Ltd. |
Resorbierbare feste Zusammensetzungen zur topischen Behandlung von Störungen der Mundschleimhaut
|
US8980334B2
(en)
|
2001-02-28 |
2015-03-17 |
Axiomedic Ltd. |
Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US7425292B2
(en)
*
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US20070154527A1
(en)
*
|
2001-10-12 |
2007-07-05 |
Monosoirx, Llc |
Topical film compositions for delivery of actives
|
US20100021526A1
(en)
*
|
2001-10-12 |
2010-01-28 |
Monosol Rx, Llc |
Ph modulated films for delivery of actives
|
US7910641B2
(en)
*
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US20060039958A1
(en)
*
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US20110033542A1
(en)
*
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
GB2384986B
(en)
*
|
2002-02-12 |
2004-01-07 |
Reckitt Benckiser Healthcare |
Compositions for the treatment of disorders of the upper gastrointestinal tract
|
US20030167556A1
(en)
*
|
2002-03-05 |
2003-09-11 |
Consumers Choice Systems, Inc. |
Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
|
US8017150B2
(en)
*
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
JP5570677B2
(ja)
*
|
2002-04-25 |
2014-08-13 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
α−ガラクトシダーゼA欠損症の治療
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
WO2004009445A2
(en)
*
|
2002-07-22 |
2004-01-29 |
Kosmos Pharma |
Packaging and dispensing of rapid dissolve dosage form
|
DE10252726B4
(de)
|
2002-11-13 |
2008-05-08 |
Lts Lohmann Therapie-Systeme Ag |
Mehrschichtiges transmucosales therapeutisches System
|
IL153124A
(en)
*
|
2002-11-27 |
2010-06-30 |
Herbal Synthesis Corp |
Solid composition that can be glued to the lining
|
US7306812B2
(en)
*
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
SI1644389T1
(sl)
*
|
2003-06-16 |
2011-06-30 |
Acad Of Science Czech Republic |
Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
FR2865648B1
(fr)
*
|
2004-02-03 |
2006-06-30 |
Philippe Perovitch |
Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
|
US7906140B2
(en)
*
|
2004-06-17 |
2011-03-15 |
Virun, Inc. |
Compositions for mucosal delivery of agents
|
CA2518650A1
(en)
*
|
2004-09-10 |
2006-03-10 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
WO2007067964A2
(en)
*
|
2005-12-08 |
2007-06-14 |
Nastech Pharmaceutical Company Inc. |
Mucosal delivery of stabilized formulations of exendin
|
US20070185035A1
(en)
*
|
2005-12-23 |
2007-08-09 |
Nastech Pharmaceutical Company Inc. |
Enhanced mucosal administration of neuroprotective peptides
|
CA2636026A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Monosol Rx, Llc |
Film lined pouch and method of manufacturing this pouch
|
EP1986602A2
(de)
*
|
2006-01-20 |
2008-11-05 |
MonoSol Rx LLC |
Folienverband zur verabreichung von wirkstoffen auf die schleimhaut
|
KR101230804B1
(ko)
|
2006-07-21 |
2013-02-08 |
바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 |
향상된 흡수를 갖는 경점막 전달 장치
|
EP2063864A4
(de)
*
|
2006-09-20 |
2012-03-14 |
Monosol Rx Llc |
Verzehrbare wasserlösliche folie mit einem schäumungsreduzierenden geschmacksmittel
|
CA2664615A1
(en)
*
|
2006-09-29 |
2008-04-10 |
Monosol Rx, Llc |
Film embedded packaging and method of making same
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
JP2011522616A
(ja)
*
|
2008-06-04 |
2011-08-04 |
セブンス センス バイオシステムズ,インコーポレーテッド |
シングルステップ診断のための組成物および方法
|
KR20110043661A
(ko)
*
|
2008-08-12 |
2011-04-27 |
노바베이 파마슈티칼즈, 인코포레이티드 |
항미생물 젤 제형물
|
US20110105952A1
(en)
*
|
2009-10-30 |
2011-05-05 |
Seventh Sense Biosystems, Inc. |
Relatively small devices applied to the skin, modular systems, and methods of use thereof
|
WO2010101620A2
(en)
|
2009-03-02 |
2010-09-10 |
Seventh Sense Biosystems, Inc. |
Systems and methods for creating and using suction blisters or other pooled regions of fluid within the skin
|
US20120277629A1
(en)
|
2011-04-29 |
2012-11-01 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collection and/or manipulation of blood spots or other bodily fluids
|
WO2012018486A2
(en)
|
2010-07-26 |
2012-02-09 |
Seventh Sense Biosystems, Inc. |
Rapid delivery and/or receiving of fluids
|
US20110288389A9
(en)
|
2009-03-02 |
2011-11-24 |
Seventh Sense Biosystems, Inc. |
Oxygen sensor
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
EP2493537B1
(de)
*
|
2009-10-30 |
2017-12-06 |
Seventh Sense Biosystems, Inc. |
Systeme und verfahren zur behandlung, desinfektion und/oder abschirmung der haut oder von auf der haut angebrachten vorrichtungen
|
US8701671B2
(en)
|
2011-02-04 |
2014-04-22 |
Joseph E. Kovarik |
Non-surgical method and system for reducing snoring
|
US9549842B2
(en)
|
2011-02-04 |
2017-01-24 |
Joseph E. Kovarik |
Buccal bioadhesive strip and method of treating snoring and sleep apnea
|
CA2785468A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
WO2011094573A1
(en)
|
2010-01-28 |
2011-08-04 |
Seventh Sense Biosystems, Inc. |
Monitoring or feedback systems and methods
|
US8974826B2
(en)
|
2010-06-10 |
2015-03-10 |
Monosol Rx, Llc |
Nanoparticle film delivery systems
|
WO2011163347A2
(en)
|
2010-06-23 |
2011-12-29 |
Seventh Sense Biosystems, Inc. |
Sampling devices and methods involving relatively little pain
|
WO2012009613A1
(en)
|
2010-07-16 |
2012-01-19 |
Seventh Sense Biosystems, Inc. |
Low-pressure environment for fluid transfer devices
|
WO2012021801A2
(en)
|
2010-08-13 |
2012-02-16 |
Seventh Sense Biosystems, Inc. |
Systems and techniques for monitoring subjects
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
WO2012064802A1
(en)
|
2010-11-09 |
2012-05-18 |
Seventh Sense Biosystems, Inc. |
Systems and interfaces for blood sampling
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
WO2012149155A1
(en)
|
2011-04-29 |
2012-11-01 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collecting fluid from a subject
|
US20130158468A1
(en)
|
2011-12-19 |
2013-06-20 |
Seventh Sense Biosystems, Inc. |
Delivering and/or receiving material with respect to a subject surface
|
EP2701600B1
(de)
|
2011-04-29 |
2016-06-08 |
Seventh Sense Biosystems, Inc. |
Ausgabe und/oder aufnahme von flüssigkeiten
|
JP6158810B2
(ja)
|
2011-08-18 |
2017-07-05 |
バイオデリバリー サイエンシズ インターナショナル,インコーポレーテッド |
ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
CA2866170A1
(en)
|
2012-03-12 |
2013-09-19 |
Advanced Bioadjuvants, Llc |
Adjuvant and vaccine compositions
|
US9456916B2
(en)
|
2013-03-12 |
2016-10-04 |
Medibotics Llc |
Device for selectively reducing absorption of unhealthy food
|
US9011365B2
(en)
|
2013-03-12 |
2015-04-21 |
Medibotics Llc |
Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
|
US9067070B2
(en)
|
2013-03-12 |
2015-06-30 |
Medibotics Llc |
Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
|
CN103385863B
(zh)
*
|
2013-08-05 |
2015-07-15 |
四川国康药业有限公司 |
一种薁磺酸钠缓释制剂
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
PL3145548T3
(pl)
|
2014-05-22 |
2022-08-08 |
University Of Copenhagen |
Kompozycja żelu wodnego i jej zastosowanie
|
CA2936746C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
EP3452023A1
(de)
|
2016-05-05 |
2019-03-13 |
Aquestive Therapeutics, Inc. |
Epinephrinzusammensetzungen mit verbesserter freisetzung
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|